`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`CLARKSBURG DIVISION
`
`
`
`
`Case No. 1:22-cv-00061-TSK
`
`JURY TRIAL DEMANDED
`
`
`
`
`REGENERON PHARMACEUTICALS, INC.,
`
`
`
`
`MYLAN PHARMACEUTICALS INC., and
`BIOCON BIOLOGICS INC.,
`
`
`
`
`Plaintiff,
`
`
`v.
`
`
`
`Defendant.
`
`
`
`
`
`JOINT STIPULATION REGARDING COMMERCIAL SUCCESS
`
`
`Whereas, Plaintiff Regeneron Pharmaceuticals, Inc. (“Regeneron”) agrees that it will not
`
`assert at the June 2023 trial in this action the commercial or financial success of EYLEA as an
`
`objective indicium of non-obviousness, or in support of any other claim or defense in this June
`
`2023 trial in this action pertaining to invention(s) claimed in any of Claims 11 or 19 of U.S.
`
`Patent No. 10,888,601; Claims 4, 7, 9, 11, or 14-17 of U.S. Patent No. 11,084,865; or Claims 6
`
`or 25 of U.S. Patent No. 11,253,572, or claims that they depend upon;
`
`Regeneron and Defendants Mylan Pharmaceuticals Inc. and Biocon Biologics Inc.
`
`(collectively, the “Parties”) hereby stipulate and agree as follows:
`
`1.
`
`No Party will call Dr. Richard Manning as a witness, whether in-person or by
`
`deposition designation, at the June 2023 trial in this action concerning the above-identified
`
`claims; and
`
`
`
`1
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 552 Filed 06/22/23 Page 2 of 6 PageID #: 41778
`
`2.
`
`No Party will call Mr. Ivan T. Hofmann as a witness, whether in-person or by
`
`deposition designation, at the June 2023 trial in this action concerning the above-identified
`
`
`
`
`Respectfully submitted,
`
`
`CAREY DOUGLAS KESSLER & RUBY, PLLC
`
`/s/ David R. Pogue
`Steven R. Ruby (WVSB No. 10752)
`David R. Pogue (WVSB No. 10806)
`707 Virginia Street East
`901 Chase Tower (25301)
`P.O. Box 913
`Charleston, West Virginia 25323
`(304) 345-1234
`sruby@cdkrlaw.com
`drpogue@cdkrlaw.com
`
`
`
`claims.
`
`
`Date: June 22, 2023
`
`
`Of Counsel:
`
`David I. Berl (admitted PHV)
`Ellen E. Oberwetter (admitted PHV)
`Thomas S. Fletcher (admitted PHV)
`Andrew V. Trask (admitted PHV)
`Teagan J. Gregory (admitted PHV)
`Shaun P. Mahaffy (admitted PHV)
`Sean M. Douglass (admitted PHV)
`Kathryn S. Kayali (admitted PHV)
`Arthur J. Argall III (admitted PHV)
`Adam Pan (admitted PHV)
`Nicholas Jordan (admitted PHV)
`Haylee Bernal Anderson (admitted PHV)
`Renee Griffin (admitted PHV)
`Rebecca Carter (admitted PHV)
`WILLIAMS & CONNOLLY LLP
`680 Maine Avenue, SW
`Washington, DC 20024
`(202) 434-5000
`dberl@wc.com
`eoberwetter@wc.com
`tfletcher@wc.com
`atrask@wc.com
`tgregory@wc.com
`smahaffy@wc.com
`sdouglass@wc.com
`kkayali@wc.com
`aargall@wc.com
`apan@wc.com
`njordan@wc.com
`handerson@wc.com
`rgriffin@wc.com
`rebeccacarter@wc.com
`
`
`
`
`2
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 552 Filed 06/22/23 Page 3 of 6 PageID #: 41779
`
`Andrew E. Goldsmith (admitted PHV)
`Evan T. Leo (admitted PHV)
`Jacob E. Hartman (admitted PHV)
`Grace W. Knofczynski (admitted PHV)
`Mary Charlotte Y. Carroll (admitted PHV)
`Sven E. Henningson (admitted PHV)
`KELLOGG, HANSEN, TODD, FIGEL &
` FREDERICK, P.L.L.C.
`1615 M Street, NW, Suite 400
`Washington, DC 20036
`TEL: (202) 326-7900
`agoldsmith@kellogghansen.com
`eleo@kellogghansen.com
`jhartman@kellogghansen.com
`gknofczynski@kellogghansen.com
`mcarroll@kellogghansen.com
`shenningson@kellogghansen.com
`
`Counsel for Plaintiff Regeneron Pharmaceuticals, Inc.
`
`
`
`
`
`3
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 552 Filed 06/22/23 Page 4 of 6 PageID #: 41780
`
`
`Dated: June 22, 2023
`
`
`Of Counsel (admitted pro hac vice):
`William A. Rakoczy
`Deanne M. Mazzochi
`Heinz J. Salmen
`Eric R. Hunt
`Jeff A. Marx
`Neil B. McLaughlin
`Lauren M. Lesko
`L. Scott Beall
`Thomas H. Ehrich
`Steven J. Birkos
`Katie A. Boda
`Abraham J. Varon
`Jake R. Ritthamel
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 W. Hubbard St., Suite 500
`Chicago, IL 60654
`(312) 527-2157
`wrakoczy@rmmslegal.com
`dmazzochi@rmmslegal.com
`hsalmen@rmmslegal.com
`ehunt@rmmslegal.com
`jmarx@rmmslegal.com
`nmclaughlin@rmmslegal.com
`llesko@rmmslegal.com
`sbeall@rmmslegal.com
`tehrich@rmmslegal.com
`sbirkos@rmmslegal.com
`kboda@rmmslegal.com
`avaron@rmmslegal.com
`jritthamel@rmmslegal.com
`
`
`
`
`
`
`STEPTOE & JOHNSON PLLC
`
`/s/ William J. O’Brien
`Gordon H. Copland (WVSB #828)
`William J. O’Brien (WVSB #10549)
`400 White Oaks Boulevard
`Bridgeport, WV 26330
`(304) 933-8162
`gordon.copland@steptoe-johnson.com
`william.obrien@steptoe-johnson.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Counsel for Defendant
`Mylan Pharmaceuticals Inc.
`
`
`
`
`4
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 552 Filed 06/22/23 Page 5 of 6 PageID #: 41781
`
`
`
`Having reviewed the parties’ stipulation, the provisions thereof are APPROVED and it is
`
`SO ORDERED.
`
`DATED: ______________________
`
`
`
`_______________________________________
`THOMAS S. KLEEH, CHIEF JUDGE
`NORTHERN DISTRICT OF WEST VIRGINIA
`
`
`
`
`
`
`
`5
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 552 Filed 06/22/23 Page 6 of 6 PageID #: 41782
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on June 22, 2023, I electronically filed the foregoing with the Clerk
`
`of the Court by using the Court’s CM/ECF system. Counsel of record for all parties will be
`
`served by the Court’s CM/ECF system.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ David R. Pogue
`David R. Pogue (WVSB No. 10806)
`
`
`
`
`
`6
`
`